Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy
PLOS One · 09.03.2026 · 21 (3) · e0341173
DOI: 10.1371/journal.pone.0341173 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 09.03.2026. Verfasst von Alicia T Bolton und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCHHSTP CDC HHS, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Long-acting injectable antiretroviral therapy (LAI-ART) offers an alternative to daily oral treatment but is typically administered in clinics, which can create barriers for some people with HIV (PWH). Home-based administration by trained treatment buddies (TBYs)—trusted partners, friends, or family members—has not been systematically studied. We conducted semi-structured interviews with 31 participants (16 PWH and 15 TBYs) across 4 HIV clinics in the San Francisco Bay Area between June 2024 and April 2025. Guided by the Consolidated Framework for Implementation Research (CFIR), interviews explored anticipated facilitators, barriers, and training needs for home-based LAI-ART. Participants identified several anticipated benefits of home-based LAI-ART, including increased convenience, reduced transportation burdens, enhanced privacy, comforting and emotionally supportive care, and opportunities to foster empowerment and shared responsibility between PWH and TBYs. Key barriers included concerns about medication storage and delivery logistics, maintaining reliable injection schedules, needlestick safety, and the readiness and confidence of TBYs. Participants emphasized the need for hands-on training, ongoing support, and clear protocols to ensure safe, acceptable, and effective home-based administration. These findings underscore the importance of proactive planning and tailored support in addressing both the technical and emotional dimensions of home-based LAI-ART. Anticipating these needs can facilitate the successful implementation and expand access to person-centered HIV care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
- Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States of America.
ORCID-Profile: Alicia T Bolton, Beth Bourdeau
Förderung
- NCHHSTP CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Bolton, A. T., Bourdeau, B., Rebchook, G., Van Nuys, J., Moore, E., Buchacz, K., O'Shea, J., & Saberi, P. (2026). Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy. PLOS One, 21(3), e0341173. https://doi.org/10.1371/journal.pone.0341173
Vancouver
Bolton AT, Bourdeau B, Rebchook G, Van Nuys J, Moore E, Buchacz K, et al. Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy. PLOS One. 2026;21(3):e0341173. doi:10.1371/journal.pone.0341173
BibTeX
@article{Bolton2026,
author = {Bolton, Alicia T and Bourdeau, Beth and Rebchook, Greg and Van Nuys, Jonathan and Moore, Erin and Buchacz, Kate and O'Shea, Jesse and Saberi, Parya},
title = {Patient and injection partner perspectives on barriers and facilitators to home-based administration of long-acting injectable antiretroviral therapy},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0341173},
doi = {10.1371/journal.pone.0341173}
}
EUVIMED